Comparison of Molecular International Prognostic Scoring System (M-IPSS) and Revised International Prognostic Scoring System (R-IPSS) in Thai patients with myelodysplastic neoplasms.
Chantana PolprasertPimjai NiparuckThanawat RattanathammetheeSirorat KobbuakleeTheerin LanamtiengPonlapat RojnuckarinPublished in: Hematology (Amsterdam, Netherlands) (2022)
Our study showed that R-IPSS score can be used for risk stratification in most Thai patients. A prediction model using somatic mutations specifically in Asian patients should be formulated in the future.